ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)
China · Delayed Price · Currency is CNY 10.21
-0.06 (-0.58%)
May 20, 2026, 2:45 PM CST
SHA:600479 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 397.52 | 375.67 | 230.76 | 320.41 | 302.51 | 302.06 |
Depreciation & Amortization | 108 | 108 | 97.92 | 103.65 | 95.6 | 85.93 |
Other Amortization | 16.03 | 16.03 | 22.63 | 18.53 | 16.8 | 16.22 |
Loss (Gain) From Sale of Assets | -1.88 | -1.88 | -0.5 | - | - | -33.54 |
Asset Writedown & Restructuring Costs | 2.26 | 2.26 | 4.69 | 0.94 | -0.17 | 0.43 |
Loss (Gain) From Sale of Investments | -44.19 | -44.19 | -16.22 | -15.87 | -19.65 | -26.41 |
Provision & Write-off of Bad Debts | - | - | 5.61 | 17.84 | 2.17 | -0.29 |
Other Operating Activities | 5.39 | 4.52 | 78.83 | 79.28 | 88.17 | 75.41 |
Change in Accounts Receivable | -180.78 | -180.78 | 18.73 | -8.69 | -163.72 | 275.85 |
Change in Inventory | -8.47 | -8.47 | 44.61 | 62.29 | -51.22 | -52.4 |
Change in Accounts Payable | 244.4 | 244.4 | -147.8 | -132.49 | 465.43 | -160.39 |
Change in Other Net Operating Assets | -35.42 | -35.42 | 60.88 | - | - | - |
Operating Cash Flow | 502.96 | 480.24 | 398.77 | 443.12 | 733.47 | 485.57 |
Operating Cash Flow Growth | 13.13% | 20.43% | -10.01% | -39.59% | 51.05% | -10.47% |
Capital Expenditures | -142.98 | -124.17 | -47.32 | -43.99 | -34.43 | -71.88 |
Sale of Property, Plant & Equipment | 2.22 | 2.22 | 0.39 | 0.06 | 0.2 | 30.82 |
Investment in Securities | -496.01 | -813.62 | -700 | 618.4 | 130.07 | -25.18 |
Other Investing Activities | 4.57 | 4.57 | 5.75 | 10.82 | 26.32 | 22.9 |
Investing Cash Flow | -632.2 | -931 | -741.18 | 585.29 | 122.15 | -43.34 |
Long-Term Debt Issued | - | - | - | 42.15 | - | 60 |
Long-Term Debt Repaid | - | -7 | -69.41 | -74.6 | -43.83 | -149.85 |
Net Debt Issued (Repaid) | -7 | -7 | -69.41 | -32.46 | -43.83 | -89.85 |
Issuance of Common Stock | 2 | 2 | - | 0.44 | 48.59 | - |
Repurchase of Common Stock | - | - | -16.54 | -3.38 | - | - |
Common Dividends Paid | -152.68 | -152.68 | -152.82 | -147.89 | -248.65 | -429.53 |
Other Financing Activities | 6.92 | 8.68 | -11.36 | -18.72 | -20.29 | -1.2 |
Financing Cash Flow | -150.76 | -149 | -250.12 | -202 | -264.19 | -520.58 |
Net Cash Flow | -280 | -599.75 | -592.54 | 826.4 | 591.43 | -78.35 |
Free Cash Flow | 359.98 | 356.08 | 351.45 | 399.13 | 699.04 | 413.69 |
Free Cash Flow Growth | -10.76% | 1.32% | -11.95% | -42.90% | 68.97% | -7.06% |
Free Cash Flow Margin | 10.02% | 9.81% | 9.68% | 10.51% | 17.36% | 11.29% |
Free Cash Flow Per Share | 0.80 | 0.83 | 0.85 | 0.94 | 1.63 | 0.99 |
Cash Income Tax Paid | 339.61 | 330.15 | 347.79 | 329.57 | 290.93 | 319.05 |
Levered Free Cash Flow | 372.91 | 352.11 | 226.34 | 241.45 | 716.2 | 333.96 |
Unlevered Free Cash Flow | 372.91 | 352.11 | 227.04 | 242.5 | 717.59 | 335.28 |
Change in Working Capital | 19.83 | 19.83 | -24.94 | -81.67 | 248.05 | 65.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.